Skip to main content
. 2023 Mar 9;35:100738. doi: 10.1016/j.lanwpc.2023.100738

Fig. 4.

Fig. 4

Cost-effectiveness acceptability curves for HBV treatment strategies of the HBV treatment programs by 2050 implemented from 2023, 2028, and 2033. Strategies on the cost-effectiveness frontier dominate strategies above the frontier.